THE SECRET OF LONG LIFE REVEALED: DRINK UP 3 CUPS OF COFFEE DAILY

Reading time is 2 mins

.
.
THE SECRET OF A LONG LIFE REVEALED BY 10 YEARS OF RESEARCH: DRINK UP TO THREE CUPS OF COFFEE EVERY DAY

– A new proposal has come from scientists for the secret of long life, which has always been the subject of curiosity of the scientific world. Researchers who recommend drinking up to three cups of coffee a day also emphasize that it should be ground coffee.

– According to a decade-long study, drinking three cups of coffee every day can help you live longer. According to the study, those who regularly drank coffee were up to 12 percent less likely to die.

– According to the results of the research; it was found that people who drink coffee are one-fifth less likely to develop cardiovascular disease or have a stroke. However, experts have also emphasized that the health benefits of coffee are possible only by consuming ground coffee.

– According to a study conducted by about 500 thousand people, it was noted that drinking more than three glasses a day has no positive effect.

.
IT PREVENTS DISEASES SUCH AS CANCER AND DEMENTIA

– Coffee is one of the most consumed beverages in the world, but earlier research had yielded conflicting results on whether coffee is beneficial or harmful to health.

– In addition to caffeine in terms of content, coffee also contains minerals and antioxidants. In fact, some studies have suggested that drinking coffee in terms of content reduces the risk of cancer, type 2 diabetes and dementia, while some researchers have also pointed out that the risk of dying from high blood pressure and cardiovascular disease increases.

– The new study by a team of academics suggests that the drink does not increase blood pressure and has cardiovascular benefits. Dr., one of the study authors, said the results showed that moderate coffee consumption “is not harmful to the cardiovascular system and may even be beneficial.

.
THEY POINTED OUT THAT IT SHOULD BE GROUND COFFEE

– The study participants were selected from people who were on average 56 years old and had no heart disease when the study began. The volunteers were followed for 11 years, and the specialists were allowed to dec the differences between the groups. 22 percent of the participants were non-coffee drinkers and 58 percent drank up to three cups of coffee a day.

– The results showed that those who drank between 0.5-3 cups a day were 12 percent less likely to die at the end of the study than those who did not drink decaf. In addition, they were 17 percent less likely to die from cardiovascular disease and 21 percent less likely to have a stroke compared to those who did not drink coffee. They were also less likely to be diabetic than those who never drank coffee. Although researchers have not yet studied the cause of this condition, caffeine is known to suppress appetite, which can lead to lower rates of obesity and related health conditions.

.
THE TYPE OF COFFEE CONSUMED IS IMPORTANT

– The researchers found no increase in high blood pressure rates among coffee drinkers, which quelled concerns that the decaffeinated drink was triggering the condition.

– However, when the group looked at the health benefits according to the type of coffee the participants drank, it was found that there was no positive effect of coffee on those who consumed instant coffee. This is probably due to differences in how coffee is made, the researchers said.

– Instant coffee contains more caffeine and antioxidants, but it contains twice as much the acrylamide. Acrylamide, a substance found in some foods, has been linked to an increased risk of cancer and nervous system damage.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me